Peter Damsbo, MD

Peter Damsbo, MD

Peter Damsbo, MD, from Copenhagen University, has more than 25 years of experience from life science industry and science, including several years in the United States heading up clinical development of diabetes products for Novo Nordisk. Key positions prior to joining Kinexum include Chief Development Officer at Zealand Pharma, Vice President Clinical Drug Development at Novo Nordisk Headquarter, Medical Director Diabetes at Novo Nordisk USA, and Research Fellow at the Steno Diabetes Center focused on research in Type 2 diabetes (more than 20 peer reviewed papers). During his industry career, Peter Damsbo has carried 3 medical projects from preclinical phase through to worldwide registration, including writing the expert reports and presented at meetings and hearings with Health authorities. He has experience in medical device development and conducted numerous drug concept evaluations as well as been involved in drug licensing deals and due diligence processes.   Peter Damsbo has experience in interacting with the health authorities in a number of countries, including most notably FDA and EMEA. He has Attended the Advanced Management Program at INSEAD, Managing Medical Product Innovation at SIMI and Product Business Planning: ‘How do we extract maximum value from our Projects’ by Prof. Ralph Boscheck, IMD   His medical expertise spans over several therapeutic areas, including diabetes, obesity, and metabolic diseases and inflammatory diseases, and includes medical devices across the areas. He is partner in Ventac Partners, a venture catalyst in life science and is associated to the Danish-based KLIFO’s Drug Development Counselling groups.

Leadership List

Officers

G. Alexander Fleming, MD
Executive Chairman

Thomas Seoh
President and Chief Executive Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Peter Damsbo, MD

Rob Walsh, MD

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

 

Regulatory Affairs

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

David Reinhold Brill, Ph.D

Dia Hill

Doug Muchmore, MD

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Joyce Reyes

Lana Pauls, MPH

Michael Sharp, Ph.D

Scot Faulkner, MPA

 

EU Regulatory

Catherine Bernard, Ph.D

Michael Trautmann, MD

 

Clinical Operations/Project Management

Chris Yun

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lana Pauls, MPH

Lynn Schaich

Susan Manley

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Marijke Adams PharmD, Ph.D

Monalisa Chatterji,Ph.D

Virgil Whitehurst, Ph.D

 

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Joyce Reyes

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Michael Sharp, Ph.D

Rob Walsh, MD

 

 QA/QC

Joshua Sharlin, Ph.D

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Lynn Schaich

Robert Kaster, RPh., ASQ-CQA

 

Medical Writing/Electronic Submissions

Brandon Jones

Dahlia Sperling

Sandor Bernath, Ph.D, MBA

 

Process & Innovation Management

Elizabeth Whalley Buono, BSN, RN, MBA, JD

Scot Faulkner, MPA

 

Defense & National Security Practice

Dean E.Calcagni, MD

 

Commercializing and Business & Corporate Strategy

Lisa Jansa, MBA

Martin Lafontaine

Stephen Casey, MBA

Thomas Seoh

 

Kinexum Associate

Jennifer Zhao

 

Founders

G. Alexander Fleming, MD

Lisa Jansa, MBA